Search

Your search keyword '"Jeon-Slaughter, Haekyung"' showing total 49 results
Start Over Author "Jeon-Slaughter, Haekyung" Search Limiters Full Text
49 results on '"Jeon-Slaughter, Haekyung"'

9. Comparative Assessment of Procedure Cost and Outcomes Between Guidewire and Crossing Device Strategies to Cross Peripheral Artery Chronic Total Occlusions

Author

Banerjee, Subhash, Jeon-Slaughter, Haekyung, Tsai, Shirling, Mohammad, Atif, Foteh, Mazin, Abu-Fadel, Mazen, Gigliotti, Osvaldo S., Cawich, Ian, Rodriguez, Gerardo, Kumbhani, Dharam, Addo, Tayo, Luna, Michael, Das, Tony S., Prasad, Anand, Armstrong, Ehrin J., Shammas, Nicolas W., and Brilakis, Emmanouil S.

Published
2016
Full Text
View/download PDF

17. Hippocampal Volume Is Reduced in Schizophrenia and Schizoaffective Disorder But Not in Psychotic Bipolar I Disorder Demonstrated by Both Manual Tracing and Automated Parcellation (FreeSurfer)

Author

Arnold, Sara J. M., Ivleva, Elena I., Gopal, Tejas A., Reddy, Anil P., Jeon-Slaughter, Haekyung, Sacco, Carolyn B., Francis, Alan N., Tandon, Neeraj, Bidesi, Anup S., Witte, Bradley, Poudyal, Gaurav, Pearlson, Godfrey D., Sweeney, John A., Clementz, Brett A., Keshavan, Matcheri S., and Tamminga, Carol A.

Published
2015
Full Text
View/download PDF

31. TCT-763 Comparative Assessment of Infrainguinal CTO Crossing Devices

Author

Abdullah, Kazeen, primary, Armstrong, Ehrin, additional, Jeon-Slaughter, Haekyung, additional, Shammas, Nicolas W., additional, Niazi, Khusrow, additional, Kinlay, Scott, additional, Abu-Fadel, Mazen, additional, Prasad, Anand, additional, Khalili, Houman, additional, Ramanan, Bala, additional, and Brilakis, Emmanouil, additional

Published
2017
Full Text
View/download PDF

32. TCT-60 Stent Versus Non-Stent Strategies For Endovascular Treatment of Femoropopliteal Peripheral Artery Disease: Insights From the XLPAD Registry

Author

Steinbrecher, Micah, primary, Sun, Bo, additional, Armstrong, Ehrin, additional, Jeon-Slaughter, Haekyung, additional, Shammas, Nicolas W., additional, Niazi, Khusrow, additional, Kinlay, Scott, additional, Abu-Fadel, Mazen, additional, Prasad, Anand, additional, Khalili, Houman, additional, Ali, Mujtaba, additional, Ramanan, Bala, additional, and Brilakis, Emmanouil, additional

Published
2017
Full Text
View/download PDF

33. PREDICTORS OF PROCEDURAL COMPLICATIONS IN INFRAINGUINAL ENDOVASCULAR INTERVENTIONS

Author

Danek, Barbara Anna, primary, Khalili, Houman, additional, Jeon-Slaughter, Haekyung, additional, Baskar, Amutharani, additional, Armstrong, Ehrin, additional, Shammas, Nicolas, additional, Shammas, Andrew, additional, Cawich, Ian, additional, Rodriguez, Gerardo, additional, Abu-Fadel, Mazen, additional, Prasad, Anand, additional, Brilakis, Emmanouil, additional, and Banerjee, Subhash, additional

Published
2017
Full Text
View/download PDF

34. UTILIZATION OF DISTAL EMBOLIC PROTECTION IN INFRAINGUINAL PERIPHERAL ARTERIAL INTERVENTION: INSIGHTS FROM THE MULTICENTER XLPAD REGISTRY

Author

Khalili, Houman, primary, Jeon-Slaughter, Haekyung, additional, Tejani, Ishita, additional, Baskar, Amutharani, additional, Armstrong, Ehrin, additional, Shammas, Nicolas, additional, Shammas, Andrew, additional, Prasad, Anand, additional, Cawich, Ian, additional, Rodriguez, Gerardo, additional, Abu-Fadel, Mazen, additional, Brilakis, Emmanouil, additional, and Banerjee, Subhash, additional

Published
2017
Full Text
View/download PDF

35. ASSOCIATION OF CIGARETTE SMOKING WITH PROCEDURAL COST OF LOWER EXTREMITY ENDOVASCULAR INTERVENTION

Author

Jeon-Slaughter, Haekyung, primary, Whyne, Erum Z., additional, Tsai, Shirling, additional, Tejani, Ishita, additional, Baskar, Amutharani, additional, Armstrong, Ehrin, additional, Shammas, Nicolas, additional, Rodriguez, Gerardo, additional, Abu-Fadel, Mazen, additional, Cawich, Ian, additional, Prasad, Anand, additional, Brilakis, Emmanouil, additional, and Banerjee, Subhash, additional

Published
2017
Full Text
View/download PDF

36. ATHERECTOMY IS ASSOCIATED WITH LOWER RATES OF REPEAT INTERVENTION AFTER BELOW KNEE PERIPHERAL VASCULAR INTERVENTION

Author

Khalili, Houman, primary, Jeon-Slaughter, Haekyung, additional, Baskar, Amutharani, additional, Armstrong, Ehrin, additional, Shammas, Nicolas, additional, Shammas, Andrew, additional, Prasad, Anand, additional, Cawich, Ian, additional, Rodriguez, Gerardo, additional, Abu-Fadel, Mazen, additional, Brilakis, Emmanouil, additional, and Banerjee, Subhash, additional

Published
2017
Full Text
View/download PDF

37. COMPARATIVE ASSESSMENT OF SUBINTIMAL VERSUS INTRALUMINAL CROSSING OF INFRAINGUINAL CHRONIC TOTAL OCCLUSION LESIONS

Author

Kondapalli, Ananya, primary, Jeon-Slaughter, Haekyung, additional, Armstrong, Ehrin, additional, Shammas, Nicolas, additional, Shammas, Andrew, additional, Prasad, Anand, additional, Cawich, Ian, additional, Rodriguez, Gerardo, additional, Abu-Fadel, Mazen, additional, Brilakis, Emmanouil, additional, and Banerjee, Subhash, additional

Published
2017
Full Text
View/download PDF

39. CRT-300.20 Comparative Assessment of Subintimal versus Intraluminal Crossing of Infrainguinal Chronic Total Occlusion Lesions

Author

Kondapalli, Ananya V., primary, Jeon-Slaughter, Haekyung, additional, Armstrong, Ehrin, additional, Shammas, Nicolas W., additional, Shammas, Andrew, additional, Prasad, Anand, additional, Cawich, Ian, additional, Rodriguez, Gerardo, additional, Abu-Fadel, Mazen, additional, Brilakis, Emmanouil S., additional, and Banerjee, Subhash, additional

Published
2017
Full Text
View/download PDF

42. Femoropopliteal Artery Stent Thrombosis

Author

Banerjee, Subhash, primary, Sarode, Karan, additional, Mohammad, Atif, additional, Gigliotti, Osvaldo, additional, Baig, Mirza S., additional, Tsai, Shirling, additional, Shammas, Nicolas W., additional, Prasad, Anand, additional, Abu-Fadel, Mazen, additional, Klein, Andrew, additional, Armstrong, Ehrin J., additional, Jeon-Slaughter, Haekyung, additional, Brilakis, Emmanouil S., additional, and Bhatt, Deepak L., additional

Published
2016
Full Text
View/download PDF

45. Hippocampal Volume in Healthy Controls Given 3-Day Stress Doses of Hydrocortisone.

Author

Brown, E Sherwood, Jeon-Slaughter, Haekyung, Lu, Hanzhang, Jamadar, Rhoda, Issac, Sruthy, Shad, Mujeeb, Denniston, Daren, Tamminga, Carol, Nakamura, Alyson, and Thomas, Binu P

Subjects
*HYDROCORTISONE, *HIPPOCAMPUS (Brain), *PHENYTOIN, *CUSHING'S syndrome, *ADRENOCORTICAL hormones, *RANDOMIZED controlled trials, *NEUROPSYCHOPHARMACOLOGY
Abstract

In animal models, corticosterone elevations are associated with hippocampal changes that can be prevented with phenytoin. In humans, Cushing's syndrome and long-term prescription corticosteroid use are associated with a reduction in the hippocampal volume. However, little is known about the effects of short-term corticosteroid administration on the hippocampus. The current report examines changes in the hippocampal volume during a brief hydrocortisone exposure and whether volumetric changes can be blocked by phenytoin. A randomized, double-blind, placebo-controlled, within-subject crossover study was conducted in healthy adults (n=17). Participants received hydrocortisone (160 mg/day)/placebo, phenytoin/placebo, both medications together, or placebo/placebo, with 21-day washouts between the conditions. Structural MRI scans and cortisol levels were obtained following each medication condition. No significant difference in the total brain volume was observed with hydrocortisone. However, hydrocortisone was associated with a significant 1.69% reduction in the total hippocampal volume compared with placebo. Phenytoin blocked the volume reduction associated with hydrocortisone. Reduction in hippocampal volume correlated with the change in cortisol levels (r=−0.58, P=0.03). To our knowledge, this is the first report of structural hippocampal changes with brief corticosteroid exposure. The correlation between the change in hippocampal volume and cortisol level suggests that the volume changes are related to cortisol elevation. Although the findings from this pilot study need replication, they suggest that the reductions in hippocampal volume occur even during brief exposure to corticosteroids, and that hippocampal changes can, as in animal models, be blocked by phenytoin. The results may have implications both for understanding the response of the hippocampus to stress as well as for patients receiving prescription corticosteroids. [ABSTRACT FROM AUTHOR]

Published
2015
Full Text
View/download PDF

46. Abstract 13694: Developing a Veterans Affairs Women Atherosclerotic Cardiovascular Risk Assessment Model From Veterans Affairs National Electronic Health Records Data

Author

Jeon-Slaughter, Haekyung, Chen, Xiaofei, Ramanan, Bala, and Tsai, Shirling

Abstract

Introduction:Current prediction models for atherosclerotic cardiovascular disease (ASCVD) risk demonstrate poor fit for minority groups and do not account for non-traditional risk factors that may impact ASCVD risk in women.Hypothesis:Military service earlier in life may alter the effect of age on ASCVD risk, thus increasing ASCVD risk for women service members at a younger age (<40 years).Methods:We retrospectively followed 76,559 women active-duty service members and veterans aged 30-79 from 2007 to 2017 in the national Veterans Affairs (VA) Electronic Health Record (EHR). ASCVD events include non-fatal myocardial infarction, non-fatal and fatal stroke, and cardiac deaths. Cox proportional hazard model, with covariates of age, systolic blood pressure (treated/untreated), total cholesterol and HDL, smoking status, diabetes and presence of major depression, was performed. The prediction accuracy of the VA women model was assessed by discrimination (Area under the receiver operating curve, AUC) and calibration plots.Results:ASCVD risk factors in VA women are shown in Table 1. The new VA Women ASCVD risk model demonstrates a log-linear relationship between age and ASCVD risk, and includes major depression as a new risk factor. The VA women ASCVD model correctly classified ASCVD events with an AUC ? 0.7 (White 0.7, AA 0.8, Hispanics 0.8) and calibration plots along the 45 degree line (Figure 1).Conclusions:Our VA Women ASCVD risk model proposes a log-linear aging trajectory, applicable even to women under age 40, and includes the impact of non-traditional risk factors such as major depression. The predictive accuracy applies to multiple race groups, including Hispanics.

Published
2019
Full Text
View/download PDF

47. Economics of scientific and biomedical journals: Where do scholars stand in the debate of online journal pricing and site license ownership between libraries and publishers?

Author

Jeon, Slaughter, Haekyung, Herkovic, Andrew C., and Keller, Michael A.

Subjects
ELECTRONIC journals, SCHOLARS, LIBRARIES, PUBLISHING, COMMUNICATION, ELECTRONIC publications
Abstract

The emergence of e-journals brought a great change in scholarly communication and in the behavior of scholars. However, the importance of scholars' behavior in the pricing of scientific journal has been largely ignored in the recent debate between libraries and publishers over site license practices and pricing schemes. Stanford's survey results indicate that sharply increasing costs are the main reason for individual subscription cancellation, driving users to rely on library or other institutional subscriptions. Libraries continue to be a vital information provider in the electronic era and their bargaining power in the market and the importance of roles in scholarly communication will be increased by branding and a strong relationship with users. Publishers' strategy for thriving in the electronic era is not to lose personal subscribers. Cooperation among the three sectors - scholars, libraries, and publishers - promises optimal results for each sector more than ever. [ABSTRACT FROM AUTHOR]

Published
2005

48. Clinical Outcomes and Cost Comparisons of Stent and Non-Stent Interventions in Infrainguinal Peripheral Artery Disease: Insights From the Excellence in Peripheral Artery Disease (XLPAD) Registry.

Author

Banerjee S, Jeon-Slaughter H, Armstrong EJ, Bajzer C, Abu-Fadel M, Khalili H, Prasad A, Bou Dargham B, Kamath P, Addo T, Luna M, Gigliotti O, Foteh M, Cawich I, Kinlay S, Ali M, Ramanan B, Niazi K, Tsai S, Shammas NW, and Brilakis ES

Subjects
Aged, Angiography methods, Endovascular Procedures economics, Endovascular Procedures instrumentation, Female, Femoral Artery pathology, Femoral Artery surgery, Health Care Costs, Humans, Inguinal Canal, Male, Middle Aged, Peripheral Arterial Disease diagnostic imaging, Popliteal Artery pathology, Popliteal Artery surgery, Prognosis, Retrospective Studies, Risk Assessment, Stents statistics & numerical data, Treatment Outcome, United States, Vascular Patency physiology, Cost-Benefit Analysis, Endovascular Procedures methods, Peripheral Arterial Disease therapy, Registries, Stents economics
Abstract

Background: The contemporary limb outcomes and costs of stent-based vs non-stent based strategies in endovascular revascularization of femoropopliteal (FP) peripheral artery disease (PAD) are not well understood., Methods and Results: We present data from the ongoing United States multicenter Excellence in Peripheral Artery Disease Registry between 2006-2016 to compare stent vs non-stent treatment outcomes and associated costs in FP interventions. A total of 2910 FP interventions were performed in 2162 patients (mean age, 66 years), comprising 1339 stent based (superficial femoral artery, 93%) in 1007 patients and 1571 non-stent interventions (superficial femoral artery, 85%) in 1155 patients. A growing trend for non-stent based interventions and a declining trend in repeat revascularization rate at 1 year were observed across years of registry enrollment. Stent implantation was the prevailing strategy in treating longer FP lesions (mean length, 152 mm vs 105 mm; P<.001) and chronic total occlusions (65% vs 40%; P<.001), while stent implantation was employed less frequently when treating in-stent restenotic lesions (14% vs 20%; P<.001). Stent and non-stent interventions had similar 1-year limb outcomes in all-cause death, target-limb revascularization, target-vessel revascularization, and major or minor amputation. The average procedure costs for the stent group were significantly higher than the non-stent group ($6215 vs $4790; P<.001)., Conclusion: There is a growing trend for non-stent FP artery interventions, with a significant decline in 1-year target-limb revascularization rates over time. One-year limb outcomes in stent-based compared to non-stent interventions are similar; however, at a significantly higher procedural cost.

Published
2019

49. Comparative Effectiveness Study of Drug-Eluting and Bare-Metal Peripheral Artery Stents in Endovascular Femoropopliteal Artery Revascularization.

Author

Jeon-Slaughter H, Khalili H, Tsai S, Armstrong EJ, Shammas NW, Jawaid O, Lu H, Addo T, Gigliotti O, Abu-Fadel M, and Banerjee S

Subjects
Angiography, Arterial Occlusive Diseases diagnosis, Female, Femoral Artery diagnostic imaging, Follow-Up Studies, Humans, Male, Middle Aged, Popliteal Artery diagnostic imaging, Prosthesis Design, Retrospective Studies, Treatment Outcome, Arterial Occlusive Diseases surgery, Drug-Eluting Stents, Endovascular Procedures methods, Femoral Artery surgery, Popliteal Artery surgery, Prosthesis Implantation methods
Abstract

Objectives: Paclitaxel drug-eluting stents (DESs) have been shown to improve primary patency of femoropopliteal lesions compared to plain balloon angioplasty with provisional bare-metal stents (BMSs) in randomized controlled studies. However, data are lacking on patency outcomes of real-world DES use relative to BMS use. This study compared clinically driven target-lesion revascularization (TLR), target-vessel revascularization (TVR), and target-limb revascularization outcomes at 1 year between DES and BMS treatments in a real-world setting., Methods: The study identified 174 DES (Zilver PTX; Cook Medical) and 784 BMS femoropopliteal interventions from the available 969 Excellence in Peripheral Artery Disease (XLPAD) registry patients between October 2013 and December 2016. We analyzed both unmatched (174 DES and 784 BMS) and propensity score (PS)-matched datasets (174 for each)., Results: This study found that patients who underwent DES femoropopliteal endovascular revascularization had significantly lower TLR rates in both unmatched (hazard ratio [HR], 0.57; 95% confidence interval [CI], 0.35-0.91; P=.02) and matched data (HR, 0.50 95% CI, 0.27-0.91; P=.02). The DES group had a 43% lower TVR risk than the BMS group in the PS matched cohort (HR, 0.57; 95% CI, 0.33-0.98; P=.04). Mortality rate in the DES group (5%) was significantly higher than the BMS group in both unmatched (2%; P=.04) and matched groups (1%; P=.046) at 1 year., Conclusions: Patients treated with DES had higher lesion and vessel patency than BMS after adjusting for confounding, which included complexity of lesion characteristics and operators' clinical decision-making regarding selection of treatment modalities, in femoropopliteal endovascular interventions in a real-world registry.

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results